002907 华森制药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资21,571-1.70%21,94325,97513,55116,422
投资性房地产70,298-1.21%71,15718,97023,76225,146
固定资产551,589-2.79%567,397604,288630,462577,717
在建工程26,6093.23%25,77617,51623,55095,898
无形资产120,08212.08%107,13675,25776,79353,476
商誉0--0000
其他非流动资产147,038-10.02%163,406167,711109,26863,743
937,188-2.05%956,815909,717877,386832,402

流动资产
货币资金442,7491.18%437,565503,529429,968481,405
应收账款217,05828.16%169,364216,844163,579167,122
存货136,787-9.82%151,677114,756127,437118,567
其他流动资产156,33714.92%136,034121,821173,114121,917
952,9326.52%894,639956,949894,098889,011

流动负债
短期借款0--00012,008
应付票据0--0000
应付帐款64,53916.85%55,23348,04376,10392,045
其他流动负债124,260-6.88%133,445163,277130,867151,751
188,7990.06%188,677211,320206,970255,805
流动资产净值764,1338.24%705,962745,630687,127633,206
资产总额减流动负债1,701,3212.32%1,662,7771,655,3471,564,5131,465,609

非流动负债
长期借款0--0000
应付债券0--00250,917235,352
其他非流动负债43,020-4.09%44,85644,95747,67648,435
43,020-4.09%44,85644,957298,593283,787

总权益
    实收股本417,5960.00%417,596417,596401,691401,701
    储备项目1,240,7043.36%1,200,3251,192,794864,229780,121
股东权益1,658,3012.50%1,617,9211,610,3901,265,9201,181,822
非控股权益0--0000